By Professor Michael Proinsias Farrell

Journal articles

Larney S; Farrell M, 2017, 'Prisoner suicide: a multilevel problem', The Lancet Psychiatry, 4, pp. 894 - 895, http://dx.doi.org/10.1016/S2215-0366(17)30435-2

Quinn B; Seed C; Keller A; Maher L; Wilson D; Farrell M; Caris S; Williams J; Madden A; Thompson A; Pink J; Hellard ME, 2017, 'Re-examining blood donor deferral criteria relating to injecting drug use', International Journal of Drug Policy, 48, pp. 9 - 17, http://dx.doi.org/10.1016/j.drugpo.2017.05.058

Martire KA; clare P; courtney R; bonevski B; boland V; borland R; Doran C; Farrell M; hall W; Iredale J; siahpush M; mattick R, 2017, 'Smoking and Finances: Baseline Characteristics of Low Income Daily Smokers in the FISCALS Cohort', International Journal for Equity in Health, 16, pp. 157, http://dx.doi.org/10.1186/s12939-017-0643-6

Lappin JM; Darke S; Farrell M, 2017, 'Stroke and methamphetamine use in young adults: a review', Journal of Neurology Neuropsychiatry and Psychiatry, 88, pp. 1079 - 1091, http://dx.doi.org/10.1136/jnnp-2017-316071

Bonevski B; Borland R; Paul CL; Richmond RL; Farrell M; Baker A; Gartner CE; Lawn S; Thomas DP; Walker N, 2017, 'No smoker left behind: It’s time to tackle tobacco in Australian priority populations', Medical Journal of Australia, 207, pp. 141 - 142, http://dx.doi.org/10.5694/mja16.01425

Marsden J; Stillwell G; Jones H; Cooper A; Eastwood B; Farrell M; Lowden T; Maddalena N; Metcalfe C; Shaw J; Hickman M, 2017, 'Does exposure to opioid substitution treatment in prison reduce the risk of death after release? A national prospective observational study in England', Addiction, 112, pp. 1408 - 1418, http://dx.doi.org/10.1111/add.13779

Nielsen S; Sabioni P; Trigo JM; Ware MA; Betz-Stablein BD; Murnion B; Lintzeris N; Khor KE; Farrell M; Smith A; Le Foll B, 2017, 'Opioid-sparing effect of cannabinoids: A systematic review and meta-analysis', Neuropsychopharmacology, 42, pp. 1752 - 1765, http://dx.doi.org/10.1038/npp.2017.51

Stockings E; Farrell M, 2017, 'Drinking-reduction goals offer potential to widen the options for measuring and treating alcohol dependence', The Lancet Psychiatry, 4, pp. 430 - 431, http://dx.doi.org/10.1016/S2215-0366(17)30187-6

Saunders JB; Degenhardt L; Farrell M, 2017, 'Excessive gambling and gaming: addictive disorders?', The Lancet Psychiatry, 4, pp. 433 - 435, http://dx.doi.org/10.1016/S2215-0366(17)30210-9

Lappin JM; Sara GE; Farrell M, 2017, 'Methamphetamine-related psychosis: an opportunity for assertive intervention and prevention', Addiction, 112, pp. 927 - 928, http://dx.doi.org/10.1111/add.13663

Conroy M; Gallagher DJ; Farrell MP, 2017, 'Prevalence of BRCA1/2 mutations among an Irish cohort unrestricted by testing eligibility thresholds', JOURNAL OF CLINICAL ONCOLOGY, 35, http://dx.doi.org/10.1200/JCO.2017.35.15_suppl.e13013

Degenhardt L; Sara G; McKetin R; Roxburgh A; Dobbins T; Farrell M; Burns L; Hall WD, 2017, 'Crystalline methamphetamine use and methamphetamine-related harms in Australia', Drug and Alcohol Review, 36, pp. 160 - 170, http://dx.doi.org/10.1111/dar.12426

Stillwell G; Jones H; Shaw J; Farrell M; Marsden J, 2017, 'An evaluation of opioid substitution treatment in prison on risk of mortality in period immediately after prison: Does leaving prison on OST reduce the risk of death?', DRUG AND ALCOHOL DEPENDENCE, 171, pp. E197 - E197, http://dx.doi.org/10.1016/j.drugalcdep.2016.08.538

Campbell G; Bruno R; Cohen M; Hall W; Nielsen S; Lintzeris N; Larance B; Mattick RP; Farrell M; Degenhardt L, 2017, 'Defining problematic pharmaceutical opioid use among people prescribed opioids for chronic non-cancer pain: Different measures, same patients?', DRUG AND ALCOHOL DEPENDENCE, 171, pp. E33 - E33, http://dx.doi.org/10.1016/j.drugalcdep.2016.08.103

Ritter A; Hoang VP; Cao VL; Shanahan M; Shukla N; Perez P; Farrell M, 2017, 'Modelling heroin careers over 40 years: Social costs', DRUG AND ALCOHOL DEPENDENCE, 171, pp. E177 - E177, http://dx.doi.org/10.1016/j.drugalcdep.2016.08.486

Farrell MP; Hearty KP; Gallagher DJ, 2017, 'Prevalence of pathogenic mismatch repair mutations in an Irish cohort after clinical and molecular pre-selection.', JOURNAL OF CLINICAL ONCOLOGY, 35, http://dx.doi.org/10.1200/JCO.2017.35.4_suppl.574

Darke S; Larney S; Farrell M, 2017, 'Yes, people can die from opiate withdrawal', Addiction, 112, pp. 199 - 200, http://dx.doi.org/10.1111/add.13512

Saunders JB; Hao W; Long J; King DL; Mann K; Fauth-Bühler M; Rumpf HJ; Bowden-Jones H; Rahimi-Movaghar A; Chung T; Chan E; Bahar N; Achab S; Lee HK; Potenza M; Petry N; Spritzer D; Ambekar A; Derevensky J; Griffiths MD; Pontes HM; Kuss D; Higuchi S; Mihara S; Assangangkornchai S; Sharma M; El Kashef A; Ip P; Farrell M; Scafato E; Carragher N; Poznyak V, 2017, 'Gaming disorder: Its delineation as an important condition for diagnosis, management, and prevention', Journal of Behavioral Addictions, 6, pp. 271 - 279, http://dx.doi.org/10.1556/2006.6.2017.039

Courtney RJ; Clare P; Boland V; Martire KA; Bonevski B; Hall W; Siahpush M; Borland R; Doran CM; West R; Farrell M; Mattick RP, 2017, 'Predictors of retention in a randomised trial of smoking cessation in low-socioeconomic status Australian smokers', Addictive Behaviors, 64, pp. 13 - 20, http://dx.doi.org/10.1016/j.addbeh.2016.07.019

Van Buskirk J; Griffiths P; Farrell M; Degenhardt L, 2017, 'Trends in new psychoactive substances from surface and “dark” net monitoring', The Lancet Psychiatry, 4, pp. 16 - 18, http://dx.doi.org/10.1016/S2215-0366(16)30405-9

Nielsen S; Menon N; Larney S; Farrell M; Degenhardt L, 2016, 'Community pharmacist knowledge, attitudes and confidence regarding naloxone for overdose reversal', Addiction, 111, pp. 2177 - 2186, http://dx.doi.org/10.1111/add.13517

Lappin JM; Roxburgh A; Kaye S; Chalmers J; Sara G; Dobbins T; Burns L; Farrell M, 2016, 'Increased prevalence of self-reported psychotic illness predicted by crystal methamphetamine use: Evidence from a high-risk population', International Journal of Drug Policy, 38, pp. 16 - 20, http://dx.doi.org/10.1016/j.drugpo.2016.10.018

Marsden J; Stillwell G; Jones H; Cooper A; Eastwood B; Farrell M; Lowden T; Maddalena N; Metcalf C; Shaw J; Hickman M, 2016, 'Does exposure to opioid substitution treatment at prison release reduce the risk of death? A prospective, observational study in England', LANCET, 388, pp. 11 - 11, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000398515600012&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Casey J; Flood K; Ennis S; Doyle E; Farrell M; Lynch SA, 2016, 'Intra-familial variability associated with recessive RYR1 mutation diagnosed prenatally by exome sequencing', PRENATAL DIAGNOSIS, 36, pp. 1020 - 1026, http://dx.doi.org/10.1002/pd.4925

Darke S; Farrell M, 2016, 'Commentary on Singh et al. (2016): Still searching for the answer', Addiction (Abingdon, England), 111, pp. 1347, http://dx.doi.org/10.1111/add.13369

Gethin A; Trimingham T; Chang T; Farrell M; Ross J, 2016, 'Coping with problematic drug use in the family: An evaluation of the Stepping Stones program', Drug and alcohol review, 35, pp. 470 - 476, http://dx.doi.org/10.1111/dar.12327

Campbell G; Bruno R; Lintzeris N; Cohen M; Nielsen S; Hall W; Larance B; Mattick RP; Blyth F; Farrell M; Degenhardt L, 2016, 'Defining problematic pharmaceutical opioid use among people prescribed opioids for chronic noncancer pain: Do different measures identify the same patients?', Pain, 157, pp. 1489 - 1498, http://dx.doi.org/10.1097/j.pain.0000000000000548

Bonevski B; Guillaumier A; Shakeshaft A; Farrell M; Tzelepis F; Walsberger S; D'Este C; Paul C; Dunlop A; Searles A; Kelly P; Fry R; Stirling R; Fowlie C; Skelton E, 2016, 'An organisational change intervention for increasing the delivery of smoking cessation support in addiction treatment centres: Study protocol for a randomized controlled trial', Trials, 17, http://dx.doi.org/10.1186/s13063-016-1401-6

Farrell MP; Truman GJ; Shea R; Hughes DJ; Gallagher DJ, 2016, 'Frequency of variants of uncertain significance in BRCA1 and BRCA2 in an Irish cohort.', JOURNAL OF CLINICAL ONCOLOGY, 34, http://dx.doi.org/10.1200/JCO.2016.34.15_suppl.e13006

Gowing L; Farrell M; Ali R; White JM, 2016, 'Alpha2-adrenergic agonists for the management of opioid withdrawal', Cochrane Database of Systematic Reviews, 2016, http://dx.doi.org/10.1002/14651858.CD002024.pub5

Darke S; Farrell M, 2016, 'Response to commentaries on 'Which medications are suitable for agonist drug maintenance'', Addiction, 111, pp. 781 - 782, http://dx.doi.org/10.1111/add.13359

Darke S; Farrell M, 2016, 'Which medications are suitable for agonist drug maintenance?', Addiction, 111, pp. 767 - 774, http://dx.doi.org/10.1111/add.13158

Hoang VP; Shanahan M; Shukla N; Perez P; Farrell M; Ritter A, 2016, 'A systematic review of modelling approaches in economic evaluations of health interventions for drug and alcohol problems', BMC Health Services Research, 16, pp. 127, http://dx.doi.org/10.1186/s12913-016-1368-8

Campbell G; Bruno R; Darke S; Shand F; Hall W; Farrell M; Degenhardt L, 2016, 'Prevalence and correlates of suicidal thoughts and suicide attempts in people prescribed pharmaceutical opioids for chronic pain', Clinical Journal of Pain, 32, pp. 292 - 301, http://dx.doi.org/10.1097/AJP.0000000000000283

Larney S; Farrell M, 2016, 'Commentary on Binswanger et al. (2016): Multiple opportunities exist to improve the health and wellbeing of people released from prisons', Addiction, 111, pp. 511 - 512, http://dx.doi.org/10.1111/add.13245

Larney S; Degenhardt L; Farrell M, 2016, 'Response to Bird et al.: The importance of post-release engagement in treatment in estimating impacts on post-release deaths', Addiction, 111, pp. 560 - 561, http://dx.doi.org/10.1111/add.13208

Farrell M, 2016, 'Swift and certain approaches to reduce alcohol reoffending', The Lancet Psychiatry, 3, pp. 189 - 190, http://dx.doi.org/10.1016/S2215-0366(15)00519-2

O'Kane G; McGarrigle SA; Rehill N; Farrell MP; O'Sullivan J; Muldoon C; Mac Mathuna PM; Carney DN; Gallagher DJ, 2016, 'Levels of oxidative stress and telomeres in Lynch syndrome-associated malignancies.', JOURNAL OF CLINICAL ONCOLOGY, 34, http://dx.doi.org/10.1200/jco.2016.34.4_suppl.582

Wilson AJ; Bonevski B; Dunlop A; Shakeshaft A; Tzelepis F; Walsberger S; Farrell M; Kelly PJ; Guillaumier A, 2016, ''The lesser of two evils': A qualitative study of staff and client experiences and beliefs about addressing tobacco in addiction treatment settings', Drug and Alcohol Review, 35, pp. 92 - 101, http://dx.doi.org/10.1111/dar.12322

Ritter A; Schukla N; Shanahan M; Hoang P; Cao L; Perez P; Farrell M, 2016, 'Building a Microsimulation Model of Heroin Use Careers in Australia', The International Journal of Microsimulation, 9, pp. 140 - 176, http://dx.doi.org/10.34196/ijm.00146

Casner A; Liberatore S; Masse L; Martinez D; Haan SW; Kane J; Moore AS; Seugling R; Farrell M; Giraldez E; Nikroo A; Smalyuk VA; Remington BA, 2016, 'Experimental evidence of a bubble-merger regime for the Rayleigh-Taylor Instability at the ablation front', Journal of Physics: Conference Series, 717, pp. 012010 - 012010, http://dx.doi.org/10.1088/1742-6596/717/1/012010

Darke S; Farrell M, 2016, 'The twenty-first century opioid epidemic: What is happening and what can be done?', The Addictions Newsletter, Spring, pp. 18 - 20, http://www.apa.org/divisions/div50/Newsletters/tan-spring-2016.pdf

Mayet S; Farrell M; Mani SG, 2015, 'Opioid agonist maintenance for opioid dependent patients in prison', Cochrane Database of Systematic Reviews, 2015, http://dx.doi.org/10.1002/14651858.CD008221.pub2

Nielsen S; Larance B; Lintzeris N; Holliday S; Vanderhaven M; Hordern A; Dunlop A; Haber PS; Murnion B; Silsbury C; Johnson J; Demirkol A; Sadler C; Phung N; Campbell G; Farrell M; Cohen M; Bruno R; Hardy M; Brown A; Houseman J; Degenhardt L, 2015, 'LONGER TERM OUTCOMES FOR PHARMACEUTICAL OPIOID DEPENDENCE: 12 MONTH FINDINGS FROM AN IN-TREATMENT COHORT', DRUG AND ALCOHOL REVIEW, 34, pp. 48 - 48, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000367694000129&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Hoban B; Larance B; Gisev N; Nielsen S; Cohen M; Bruno R; Shand F; Lintzeris N; Hall W; Farrell M; Degenhardt L, 2015, 'The use of paracetamol (acetaminophen) among a community sample of people with chronic non-cancer pain prescribed opioids', International Journal of Clinical Practice, 69, pp. 1366 - 1376, http://dx.doi.org/10.1111/ijcp.12716

Larney S; Degenhardt L; Mattick RP; Farrell M, 2015, 'Variation in mortality risk of people released from prison', The Lancet Psychiatry, 2, pp. 681, http://dx.doi.org/10.1016/S2215-0366(15)00235-7

Farrell M; Marsden J; Strang J, 2015, 'Griffith Edwards, the Addiction Research Unit and research on the criminal justice system', Addiction, 110, pp. 54 - 58, http://dx.doi.org/10.1111/add.12910

Farrell M; Hall W, 2015, 'Heroin-assisted treatment: Has a controversial treatment come of age?', British Journal of Psychiatry, 207, pp. 3 - 4, http://dx.doi.org/10.1192/bjp.bp.114.160986

Smith K; Mattick RP; Bruno R; Nielsen S; Cohen M; Campbell G; Larance B; Farrell M; Degenhardt L, 2015, 'Factors associated with the development of depression in chronic non-cancer pain patients following the onset of opioid treatment for pain', Journal of Affective Disorders, 184, pp. 72 - 80, http://dx.doi.org/10.1016/j.jad.2015.05.049

Degenhardt L; Bruno R; Ali R; Lintzeris N; Farrell M; Larance B, 2015, 'The introduction of a potentially abuse deterrent oxycodone formulation: Early findings from the Australian National Opioid Medications Abuse Deterrence (NOMAD) study', Drug and Alcohol Dependence, 151, pp. 56 - 67, http://dx.doi.org/10.1016/j.drugalcdep.2015.02.038

Back to profile page